Theator, a company that has created a surgical intelligence platform, revealed on that it has extended its Series A investment round by raising $24 million. The first $15.5 million Series A round, announced in February 2021, was followed by this extension, increasing the round's total to $39.5 million. With the assistance of previous investors Blumberg Capital, Mayo Clinic, NFX, StageOne Ventures, iAngels, and former Netflix Chief Product Officer Neil Hunt, the extended investment round was once again spearheaded by Insight Partners. Ariel Cohen, the CEO and co-founder of TripActions, and other new growth investors including iCON also invested in the round.

Theator's surgical intelligence platform institutionalizes the routine capture of surgical video data, harnessing AI and computer vision to automatically analyze every operation. Surgical intelligence generates actionable insights that optimize patient outcomes, ultimately raising the standard of patient care. Theator's library of surgical video and data contains over 30K hours of video, with nearly a billion frames analyzed.

"This funding is a strong vote of confidence in our vision, team, and the field of Surgical Intelligence as the cornerstone of the future of surgery," said Dr. Tamir Wolf, CEO and Co-founder of Theator. "Surgical Intelligence is already demonstrating significant improvement in surgical quality and safety. It's thrilling to hear about the impact our partners and collaborators have achieved thus far, and we look forward to this latest investment advancing our mission to transform surgery and alleviate variability and disparity in surgical care worldwide."

With this Series A extension, Theator has raised $42.5 million to date. Since its initial Series A round last year, Theator has collaborated with Mayo Clinic and partnered with the Canadian Association of General Surgeons (CAGS).